Late Breaking Abstract - Protection by budesonide against clinically important deteriorations (CID) in patients with COPD is dependent on blood eosinophil counts (EOS)

Late Breaking Abstract - Protection by budesonide against clinically important deteriorations (CID) in patients with COPD is dependent on blood eosinophil counts (EOS)

Библиографические подробности
Главные авторы:	Bafadhel, M, Sing, D, Jenkins, C, Peterson, S, Bengtsson, T, Fageras, M
Формат:	Conference item
Опубликовано:	European Respiratory Society 2018

Схожие документы

Adding budesonide to formoterol reduces risk of clinically important deteriorations (CID) in moderate to very severe COPD
по: Bafadhel, M, и др.
Опубликовано: (2018)

Modelling peripheral blood eosinophils to identify response to budesonide in COPD: a post-hoc analysis
по: Bafadhel, M, и др.
Опубликовано: (2017)

Investigating blood eosinophil count thresholds in patients with COPD
по: Russell, R, и др.
Опубликовано: (2018)

Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD
по: Pavord, I, и др.
Опубликовано: (2017)

Case series of long-term macrolide therapy effect on eosinophil count in COPD
по: Asciak, R, и др.
Опубликовано: (2017)

Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials
по: Bafadhel, M, и др.
Опубликовано: (2018)

Blood eosinophil count and exacerbation risk in patients with COPD.
по: Kerkhof, M, и др.
Опубликовано: (2017)

Characterising non-eosinophilic COPD
по: Hambleton, K, и др.
Опубликовано: (2015)

Eosinophils in COPD: just another biomarker?
по: Bafadhel, M, и др.
Опубликовано: (2017)

Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS
по: Bafadhel M, и др.
Опубликовано: (2022-12-01)

Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis
по: Antonella Casiraghi, и др.
Опубликовано: (2020-03-01)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
по: Shrimanker, R, и др.
Опубликовано: (2017)

Variability of blood eosinophil count and prognosis of COPD exacerbations
по: Sandra Martínez-Gestoso, и др.
Опубликовано: (2021-01-01)

Blood eosinophil count as a prognostic biomarker in COPD
по: Oh YM, и др.
Опубликовано: (2018-10-01)

Eosinophil migration is enhanced towards IL-5 and eotaxin in COPD
по: Lababidi, R, и др.
Опубликовано: (2017)

Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations
по: Djamin, R, и др.
Опубликовано: (2019)

Mucoadhesive Budesonide Solution for the Treatment of Pediatric Eosinophilic Esophagitis
по: Antonio Spennacchio, и др.
Опубликовано: (2024-04-01)

Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement
по: Manzetti GM, и др.
Опубликовано: (2023-10-01)

Association between blood eosinophil count and small airway eosinophils in smokers with and without COPD
по: Tomoki Maetani, и др.
Опубликовано: (2023-10-01)

Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
по: Shigeo Muro, и др.
Опубликовано: (2021-06-01)

Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD?
по: Hambleton, K, и др.
Опубликовано: (2016)

Prediction value of neutrophil and eosinophil count at risk of COPD exacerbation
по: Tzu-Tao Chen, и др.
Опубликовано: (2023-12-01)

Current smoking reduces small airway eosinophil counts in COPD
по: Augusta Beech, и др.
Опубликовано: (2024-01-01)

Corrections to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
по: Shigeo Muro, и др.
Опубликовано: (2021-08-01)

Comparison of the peripheral blood eosinophil count using near-patient testing and standard automated laboratory measurement in healthy, asthmatic and COPD subjects
по: Hambleton, K, и др.
Опубликовано: (2017)

Association between blood eosinophil count and risk of exacerbations in patients with COPD
по: Kerkhof, M, и др.
Опубликовано: (2017)

Blood eosinophil count correlates with alveolar damage in emphysema-predominant COPD
по: Saya Nakamura, и др.
Опубликовано: (2024-10-01)

Identification of COPD Inflammatory Endotypes Using Repeated Sputum Eosinophil Counts
по: Augusta Beech, и др.
Опубликовано: (2022-10-01)

Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort
по: Greulich T, и др.
Опубликовано: (2018-09-01)

Blood eosinophil count predicts treatment failure and hospital readmission for COPD
по: Marjan Kerkhof, и др.
Опубликовано: (2020-11-01)

Budesonide/formoterol combination in COPD: a US perspective
по: Amir Sharafkhaneh, и др.
Опубликовано: (2010-10-01)

Late breaking abstract - Resistomics of sputum from COPD and healthy subjects reveals bacterial load-related prevalence of antimicrobial-resistance-encoding genes
по: Ramsheh, M, и др.
Опубликовано: (2018)

Delayed hypersensitivity reaction to orodispersible budesonide in a case with eosinophilic esophagitis
по: Caroline Michèle Andrist, и др.
Опубликовано: (2020-12-01)

Clinical implications of blood eosinophil count in patients with non-asthma–COPD overlap syndrome COPD
по: Song JH, и др.
Опубликовано: (2017-08-01)

Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD
по: Bafadhel, M, и др.
Опубликовано: (2016)

Copd in the ed: eosinophils, treatment and outcomes, data from the pre-award study
по: Russell, R, и др.
Опубликовано: (2016)

Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma
по: George, L, и др.
Опубликовано: (2019)

Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization
по: Bélanger M, и др.
Опубликовано: (2018-10-01)

Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function
по: Belchamber KBR, и др.
Опубликовано: (2018-09-01)

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
по: Bafadhel, M, и др.
Опубликовано: (2014)